BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc., (OTCBB: HXBM), a biopharmaceutical company with an extensive library of diverse bioactive peptides, today announced the appointment of Jack Clifford to its board of directors, and its progress in the achievement of strategic milestones.
